Drug Fix: US FDA’s New Guidance On One-Trial Efficacy Standard And IND Reform Pilot

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman and Editor-in-Chief Nielsen Hobbs discuss the potential impact of the US Food and Drug Administration’s new updated guidance describing the one-trial plus confirmatory evidence standard for effectiveness (:47) and the significance of advancing yet another priority of former Commissioner Martin Makary (6:47). They also talk about the details of the agency’s planned pilot program to streamline IND clearances, including questions about the program’s feasibility. (14:08).

More On These Topics From The Pink Sheet

US FDA Rewrites Effectiveness Playbook, Positions
Single-Pivotal-Trial Pathway As New Normal: insights.citeline.com/pink-sheet/r-and-d/clini…

US FDA IND Reform Pilot Would Let ‘Qualified’ Outside
Institutions Give Advice To Speed Approval: insights.citeline.com/pink-sheet/r-and-d/clini…